Testing effectiveness (Phase 2)Study completedNCT02234050
What this trial is testing
Trabectedin for Recurrent Grade II/III Meningioma
Who this might be right for
Recurrent High Grade Meningioma
European Organisation for Research and Treatment of Cancer - EORTC 90